Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions

Tuberous SclerosisAngiofibromaHypomelanotic MaculePlaque

Interventions

DRUG

NPC-12G gel

NPC-12G gel is administered topically twice a day for 52 weeks or longer

Trial Locations (1)

Graduate School of Medicine, Osaka University, Suita, Osaka